CROSSROADS STRATEGIES, LLC

Lobbying for ALKERMES, INC. · biopharmaceutical company

Filing 1st Quarter - Report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 19, 2026

Income

$50,000.00

What the client paid this registrant for the period.

Client based in

Massachusetts

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Pharmacy

Policiesimpacting pharmaceutical development, patient access, drug pricing, and supply chain.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.